Leaders in Learning: Publications of Faculty & Staff

The University of Western Ontario


Clinical Neurological Sciences: 1996-1997

 

BLUME, W. T.

Blume, W.T. 1996. Focal motor seizures and epilepsia partialis continua. The Treatment of Epilepsy: Principles & Practice. 2nd ed. E. Wyllie. Baltimore, MD: Williams & Williams. 416-422.

Blume, W.T. 1996. Motor system: anatomy, physiology, and epileptogenesis. The Treatment of Epilepsy: Principles & Practice. 2nd ed. E. Wyllie. Baltimore, MD: Williams & Williams. 82-92.

Blume, W.T. 1997. Temporal lobe epilepsy surgery in childhood: rationale for greater use. Canadian Journal of Neurological Sciences 24: 95-98.

Blume, W.T., J.P. Girvin, R.S. McLachlan, and B. Gilmore. 1997. Effective temporal lobectomy in childhood without invasive EEG. Epilepsia 38 (2): 164-167.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

McLachlan, R.S., S.D. Levin, and W.T. Blume. 1997. Treatment of Rasmussen's syndrome with Ganciclovir. Neurology 47: 925-928.

McLachlan, R.S., K.J. Rose, P.A. Derry, C. Bonnar, W.T. Blume, and J.P. Girvin. 1997. Health-related quality of life and seizure control in temporal lobe epilepsy. Annals of Neurology 41: 482-489.

 

BOLTON, C. F.

Bolton, C.F. 1996. Infections (Chapter 8). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 599-627.

Bolton, C.F., M. McKeown, R. Chen, B. Toth, and H. Remtulla. 1997. Subacute uremic and diabetic polyneuropathy. Muscle and Nerve 20 (Jan.): 59-64.

Bolton, C.F., and G.B. Young. (Editors). 1996. Baillière's Clinical Neurology: International Practice and Research, Critical Care. 5 (3). 245 pp. C.F. Bolton and G.B. Young (Guest Editors).

Bolton, C.F., and G.B. Young. 1996. Neurologic Consultation and Neurological Syndromes in Intensive Care Unit (Chapter 1). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 447-476.

Hahn, A.F.G., C.F. Bolton, N. Pillay, C. Chalk, T. Benstead, V. Bril, K. Shumak, M. Vandervoort, and T.E. Feasby. 1996. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, cross-over study. Brain 119: 1055-1066.

Hahn, A.F.G., C.F. Bolton, D. Zochodne, and T.E. Feasby. 1996. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over study. Brain 119: 1067-1077.

Nicolle, M.W., D.J. Stewart, H. Remtulla, R. Chen, and C.F. Bolton. 1996. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle and Nerve 19 (Oct.): 1328-1333.

Zifko, U.A., A.F.G. Hahn, H. Remtulla, C.F.P. George, W. Wihlidal, and C.F. Bolton. 1996. Central and peripheral respiratory electrophysiologic studies in myotonic dystrophy. Brain 119: 1911-1922.

Zochodne, D., and C.F. Bolton. 1996. Neuromuscular Disorders in the Critical Illness (Chapter 10). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 645-672.

 

BULMAN, D. E.

Ebers, G.C., D.E. Bulman, K. Kukay, and A.D. Sadovnick. 1996. A full genome search in M.S. Nature Genetics 13: 472-476.

 

CAIRNCROSS, J. G.

Cairncross, J.G. 1997. Oligodendroglioma and Mixed Gliomas(Chapter 28). Cancer of the Nervous System. P.M. Black, and J.S. Loeffler. Cambridge, UK: Blackwell Scientific. 549-557.

Clifford, S.S., R.L. Sahjpaul, and J.G. Cairncross. 1997. Chemotherapy of primary brain tumors. Neurosurgery. 2nd edition ed. McGraw-Hill. 1957-1967.

DeAngelis, L.M., and J.G. Cairncross. 1997. Tumors of the Nervous System. Textbook of Internal Medicine. 3rd ed. W.N. Kelley. Philadelphia, PA: Lippincott. 2331-2339.

Forsyth, P., and J.G. Cairncross. 1996. Chemotherapy for Malignant Glioma. Clinical Neurology - Cerebral Gliomas. 5th ed. W.K.A. Yung. London, UK: Bailliere Tindall. 371-393.

Forsyth, P., J.G. Cairncross, D. Stewart, M. Goodyear, N. Wainman, and E. Eisenhauer. 1996. Phase II trial of docetaxel in patients with recurrent malignant gliomas: a study of the National Cancer Institute of Canada. Investigational New Drugs 14: 203-206.

Forsyth, P., E. Petrov, H. Mahallati, J.G. Cairncross, P. Brasher, M.E. MacRae, N.A. Hagen, P. Barnes, and R.J. Sevick. 1997. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. Journal of Clinical Oncology 15 (5): 2076-2081.

Gao, L., Liu, D. van Meyel, J.G. Cairncross, P. Forsyth, D. Kimmel, R. Jenkins, N. Lassam, and D. Hogg. 1997. Lack of Germline Mutations of CDK4, p16INK4A and p15INK4B in families with glioma. Clinical and Cancer Research 3: 977-982.

Irish, W.D., D.R. Macdonald, and J.G. Cairncross. 1997. Measuring bias in uncontrolled brain tumor trials - to randomize or not to randomize? Canadian Journal of Neurological Sciences 24: 307-312.

Leighton, C., B.J. Fisher, G. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Mason, W., D.N. Louis, and J.G. Cairncross. 1997. Chemosensitive Gliomas in Adults: Which Ones, Why? Journal of Clinical Oncology 15: 3423-3426.

Perry, J.R., L.M. DeAngelis, S.C.J.R. Schold, P.C. Burger, M.T. Brown, H.S. Brem, W.J. Curran, C.B. Scott, M.D. Prados, R. Kaplan, and J.G. Cairncross. 1997. Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 49: 912-917.

Peterson, K., N. Paleologos, P. Forsyth, D.R. Macdonald, J.G. Cairncross, and The Oligodendroglioma Study Group. 1996. Salvage chemotherapy for oligodendroglioma. Journal of Neurosurgery 85 (Oct.): 597-601.

Schabet, M., and J.G. Cairncross. 1996. Brain Metastases from Systemic Solid Tumors (Chapter 54). Neurological Disorders: Course and Treatment. T. Brandt, L.R. Caplan, J. Dichgans, H.C. Diener, and C. Kennard. San Diego, CA: Academic Press. 605-616.

Schold, S.C.J.R., J.G. Cairncross, and R. Sahjpaul. 1996. Chemotherapy of Primary Central Nervous System Neoplasms. Neurosurgery. R.H. Wilkins, and S.S. Rengachary. New York, NY: McGraw-Hill. 1957-1966.

 

CECHETTO, D. F.

Cechetto, D.F., and R.L. Kline. 1997. Effect of Rilmenidine on Arterial Pressure and Urinary Output in the Spontaneously Hypertensive Rat. European Journal of Pharmacology 325: 47-55.

Cheung, R.T.F., and D.F. Cechetto. 1997. Colchicine Affects Cortical and Amygdalar Neurochemical Changes Differentially After Middle Cerebral Artery Occlusion in Rats. The Journal of Comparative Neurology 387: 27-41.

Cheung, R.T.F., V. Hachinski, and D.F. Cechetto. 1997. Cardiovascular Response to Stress After Middle Cerebral Artery Occlusion in Rats. Brain Research 747: 181-188.

Saleh, T.M., and D.F. Cechetto. 1996. Peptide Changes in the Parabrachial Nucleus Following Cervical Vagal Stimiulation. The Journal of Comparative Neurology 366: 390-405.

Yoon, B.W., C.A. Morillo, D.F. Cechetto, and V. Hachinski. 1997. Cerebral Hemospheric Lateralization in Cardiac Autonomic Control. Archives of Neurology 54 (June): 741-744.

 

DEL MAESTRO, R. F.

Fisher, B.J., J. Siddiqui, D.R. Macdonald, A.E.L. Cairney, D.A. Ramsay, D.G. Munoz, and R.F. Del Maestro. 1996. Malignant rhabdoid tumor of brain: An aggressive clinical entity. Canadian Journal of Neurological Sciences 23 (4): 257-263.

Haley, E.C., N.F. Kassell, C. Apperson-Hanson, M.H. Maile, W.M. Alves, R.F. Del Maestro, and the participants. 1997. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with an aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 86: 467-474.

Li, Y.S., D.A. Ramsay, D.R. Macdonald, and R.F. Del Maestro. 1997. Therapy-related changes and cytogenetic heterogeneity in human gliomas. Journal of Neuro-Oncology 32: 7-17.

 

EBERS, G. C.

Dube, M.P., M.A. Miodzienski, Z. Kibaar, M.R. Farlow, G.C. Ebers, P. Harper, E.H. Kolodny, G.A. Rouleau, and D.A. Figlewicz. 1997. Hereditary spastic paraplegia: LOD-score considerations for confirmation of linkage in a hererogeneous trait. American Journal of Human Genetics 60 (3): 625-629.

Ebers, G.C., D.E. Bulman, K. Kukay, and A.D. Sadovnick. 1996. A full genome search in M.S. Nature Genetics 13: 472-476.

Rice, G.P.A., J. Lesaux, M. Vandervoort, L. Macewan, and G.C. Ebers. 1997. Ondansetron, a 5-HT3 antagonist improves cerebellar tremor. Journal of Neurology, Neurosurgery and Psychiatry 62: 282-284.

Sibley, W.A., G.C. Ebers, F.D. Lublin, D.W. Paty, A.T. Reder, and The IFNB MS Study Group. 1996. Neutralizing antibodies during treatment of multiple sclerosis with Interferon Beta-1b. Neurology 47 (4): 889-894.

 

ELIASZIW, M.

Bowler, J.V., M. Eliasziw, R. Steenhuis, D.G. Munoz, R. Fry, H. Merskey, and V. Hachinski. 1997. Comparative evolution of Alzheimer disease, vascular dementia and mixed dementia. Archives of Neurology 54 (June): 697-703.

Donner, A.P., and M. Eliasziw. 1997. A Hierarchial Approach to Inferences Concerning Interobserver Agreement for Multinomial Data. Statistics in Medicine 16: 1097-1106.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, M. Eliasziw, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Morgenstern, L.B., A.J. Fox, B.L. Sharpe, M. Eliasziw, H.J.M. Barnett, J.C. Grotta, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. 1997. The Risks and Benefits of Carotid Endarterectomy in Patients with Near Occlusion of the Carotid Artery. Neurology 48 (April): 911-915.

Paddock-Eliasziw, L.M., M. Eliasziw, H.W.K. Barr, H.J.M. Barnett, and The North American Symptomatic Carotid Endarterectomy Trial Group (NASCET). 1996. Long-Term Prognosis and the Effect of Carotid Endarterectomy in Patients With Recurrent Ipsilateral Ischemic Events. Neurology 47 (Nov.): 1158-1162.

 

FERGUSON, G. G.

Ferguson, G.G. 1996. Angioplasty for Carotid Disease: No. Archives of Neurology 53 (July): 698-699.

 

FOX, A. J.

Forbes, G., A.J. Fox, J. Huston III, D.O. Wiebers, and J. Torner. 1996. Interobserver Variability in Angiographic Measurement and Morphologic Characterization of Intracranial Aneurysms: A Report from the International Study of Unruptured Intracranial Aneurysms. American Journal of Neuroradiology 17 (Sept.): 1407-1415.

Fox, A.J. 1996. Carotid Endarterectomy Trials. Neuroimaging Clinics of North America 6 (4): 931-938.

Fox, A.J. 1996. The Role of Angiography in the Assessment of Atherosclerotic Disease: Assessment of the Carotid Bifurcation. Neuroimaging Clinics of North America 6 (3): 645-649.

Lee, D.H., F. Gao, R.N. Rankin, D.M. Pelz, and A.J. Fox. 1996. Duplex and Color Doppler Flow Sonography of Occlusion and Near Occlusion of the Carotid Artery. American Journal of Neuroradiology 17 (Aug.): 1267-1274.

Morgenstern, L.B., A.J. Fox, B.L. Sharpe, M. Eliasziw, H.J.M. Barnett, J.C. Grotta, and The North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. 1997. The Risks and Benefits of Carotid Endarterectomy in Patients with Near Occlusion of the Carotid Artery. Neurology 48 (April): 911-915.

Pelz, D.M., S.P. Lownie, D. Rosso, and A.J. Fox. 1997. Cerebral dural arteriovenous fistulae with pial venous drainage: combined endovascular-neurosurgical therapy. Canadian Journal of Neurological Sciences 24: 210-218.

Schmidt, M., D.A. Nicolle, and A.J. Fox. 1997. Bilateral Anterior Ischemic Optic Neuropathy as a Presentation of Takayasu's Disease. Journal of Neuro-Ophthalmology 17 (3): 156-161.

Smith, R., B.K. Rutt, A.J. Fox, R.N. Rankin, and D.W. Holdsworth. 1996. Geometric Characterization of Stenosed Human Carotid Arteries. Academic Radiology 3 (11): 898-911.

 

GELB, A. W.

Avraamides, E.J.C., R.A. Craen, and A.W. Gelb. 1997. Anaesthetic Management of a Pregnant, Post Liver Transplant Patient for Dental Surgery. Anaesthesia and Intensive Care 25 (1): 68-70.

Cenic, A., T.Y. Lee, R.A. Craen, and A.W. Gelb. 1997. Helical CT Study of Cerebral Perfusion and Related Hemodynamic Parameters. Medical Imaging 1997: Physiology and Function from Multidimensional Images. Newport Beach, CA: 23 February 1997-25 February 1997. E.A. Hoffman. SPIE Proceedings, Volume 3033. Washington, DC: SPIE- The International Society for Optical Engineering. 257-267.

Dzoljic, M., and A.W. Gelb. 1997. Intravenous Aaesthetics: Some Cellular Sites of Action. European Journal of Anaesthesiology 14 (Supplement 15): 3-7.

Ganapathy, S., I.A. Herrick, A.W. Gelb, and J. Kirkby. 1997. Propofol Patient-Controlled Sedation during Hip or Knee Arthroplasty in Elderly Patients. Canadian Journal of Anaesthesia 44 (4): 385-389.

Gelb, A.W. 1997. Anesthesia for the Patient with a Brain Tumor. Current Reviews in Clinical Anesthesia 17 (25): 245-252.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, M. Eliasziw, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Mokken, F., P. Henny, F.J.M. van der Waart, A.W. Gelb, and M. Kedaria. 1996. The In Vitro and In Vivo Influence of Propofol on Hemorheological Parameters: A Randomized, Double Blind Study in Patients Undergoing Minor Orthopedic Surgery (Chapter 5). Clinical Hemorheology 16: 533-542.

Mokken, F., F.J.M. van der Waart, P. Henny, P.T. Goedhart, and A.W. Gelb. 1996. Differences in Peripheral Arterial and Venous Hemorheological Parameters (Chapter 3). Annals of Hematology 73: 135-137.

Sharpe, M.D., and A.W. Gelb. 1997. Anesthetic Management of the Patient with A Transplanted Organ. Neuroanaesthesia. J.O. Johnson, et al. The Netherlands: Kluwer Academic Publishers. 371-379.

 

GILLETT, J. M. R.

Rodenhiser, D.I., J.H. Jung, J.M.R. Gillett, M. Aarts, K. Hovland, J.D. Andrews, P.J. Ainsworth, M.B. Coulter-Mackie, and S.M. Singh. 1997. A Five-Basepair Deletion (7118 delTTA) Identified within Neurofibromatosis (NF1)Exon 39. Human Mutation 9: 473.

Rupar, C.A., J.M.R. Gillett, B.A. Gordon, D.A. Ramsay, J.L. Johnson, R.M. Garrett, K.V. Rajagopolan, J.H. Jung, G.S. Bacheyie, and A.R. Sellers. 1997. Isolated Sulfite Oxidase Deficiency. Neuropediatrics 27: 299-304.

 

GIRVIN, J. P.

Blume, W.T., J.P. Girvin, R.S. McLachlan, and B. Gilmore. 1997. Effective temporal lobectomy in childhood without invasive EEG. Epilepsia 38 (2): 164-167.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, M. Eliasziw, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

McLachlan, R.S., K.J. Rose, P.A. Derry, C. Bonnar, W.T. Blume, and J.P. Girvin. 1997. Health-related quality of life and seizure control in temporal lobe epilepsy. Annals of Neurology 41: 482-489.

 

HACHINSKI, V.

Bowler, J.V., M. Eliasziw, R. Steenhuis, D.G. Munoz, R. Fry, H. Merskey, and V. Hachinski. 1997. Comparative evolution of Alzheimer disease, vascular dementia and mixed dementia. Archives of Neurology 54 (June): 697-703.

Bowler, J.V., and V. Hachinski. 1997. Vascular Dementia (Chapter 46). Behavioural Neurology and Neuropsychology. T.E. Feinberg, and M.J. Farah. New York, NY: McGraw Hill, Health Professions Division. 589-603.

Chan, R.T.K., and V. Hachinski. 1996. Binswanger's disease: neither specific nor unique. Cerebrovascular Disease 6 (6): 257-258.

Chan, R.T.K., and V. Hachinski. 1997. The Other Dementias. Currrent Therapy in Neurological Disease. 5th ed. R.T. Johnson, and J.W. Griffin. St. Louis, MO: Mosby. 311-315.

Cheung, R.T.F., and V. Hachinski. 1997. Ischemia (Chapter 17). Molecular Mechanisms of Dementia. W. Wasco, and R.E. Tanzi. Totowa, New Jersey: Humana Press. 271-291.

Cheung, R.T.F., and V. Hachinski. 1997. Management of Vascular Dementia (Chapter 188). Primer on Cerebrovascular Diseases. London: Academic Press. 767-811.

Cheung, R.T.F., and V. Hachinski. 1997. Vascular Factors in Cognitive Decline (Chapter 6). Cognitive Decline: Strategies for Prevention. H.M. Fillit, and R.N. Butler. Oxford, UK: Greenwich Medical Media. 53-69.

Cheung, R.T.F., V. Hachinski, and D.F. Cechetto. 1997. Cardiovascular Response to Stress After Middle Cerebral Artery Occlusion in Rats. Brain Research 747: 181-188.

de Lecinana, A.M., E. Diez-Tejedor, and V. Hachinski. 1996. Tratamiento del infarto cerebral agudo (Treatment of the acute cerebral infarct). Revista Clinica Espanola 196 (3): 20-28.

Devasenapathy, A., and V. Hachinski. 1997. Vascular Cognitive Impairment: A New Approach (Chapter 7). Advances in Old Age Psychiatry: Chromosomes to Community Care. C. Holmes, and R. Howard. Petersfield, UK: Wrightson Biomedical Publishing. 79-95.

Gasecki, A.P., C. Graffagnino, and V. Hachinski. 1997. Tissue plasminogen activator in a vertebral artery dissection. Canadian Journal of Neurological Sciences 24 (2): 151-154.

Lee, D.H., and V. Hachinski. 1996. Brain Imaging In Stroke. Americal Journal of Neuroradiology 17 (Aug.): 1265-1266.

Rockwood, K., E. Elby, V. Hachinski, and D. Hogan. 1997. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Archives of Neurology 54 (Jan.): 33-39.

Yoon, B.W., C.A. Morillo, D.F. Cechetto, and V. Hachinski. 1997. Cerebral Hemospheric Lateralization in Cardiac Autonomic Control. Archives of Neurology 54 (June): 741-744.

 

HAHN, A. F. G.

Griggs, R.C., R. Tawil, R.H. Brown, B.E. Shapiro, L.J. Ptacek, P.G. McManis, M.C. Dalakas, J.R. Mendell, A.F.G. Hahn, M.P. McDermot, and The Working Group on Periodic Paralysis. 1997. Implications of molecular defects for classification and treatment of periodic paralysis. Recent Advances in Clinical Neurophysiology. J. Kimura, and H. Shibasaki. Elsevier Science B.V. 160-169.

Hahn, A.F.G. 1997. Chronic inflammatory demyelinating polyradiculoneuropathy. Current Therapy in Neurological Diseases. 5th ed. R.T. Johnson, and J.W. Griffin. Toronto, ON: Mosby. 363-368.

Hahn, A.F.G. 1996. Double-blind, randomized assessment of therapeutic plasma exchange and intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Intravenous Immunoglobulin: Research and Therapy. Proceedings from the 4th International Symposium on IVIG. Interlaken, Switzerland: 11 June 1996-13 June 1996. M.D. Kazatchkine, and A. Morell. Pearl River, NY: Parthenon Publishing Group. 269-274.

Hahn, A.F.G. 1997. Management of Guillain-Barré syndrome (GBS) (Chapter 9). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 627-644.

Hahn, A.F.G., C.F. Bolton, N. Pillay, C. Chalk, T. Benstead, V. Bril, K. Shumak, M. Vandervoort, and T.E. Feasby. 1996. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, cross-over study. Brain 119: 1055-1066.

Hahn, A.F.G., C.F. Bolton, D. Zochodne, and T.E. Feasby. 1996. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over study. Brain 119: 1067-1077.

Hahn, A.F.G., and The Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. 1997. Treatment of GBS:Comparison of plasma exchange, intravenous immunoglobulin, plasma exchange followed by IV immunoglobulin. Lancet 349: 225-230.

Kornberg, A.J., A. Pestronk, G.M. Blume, G. Lopate, J. Yue, and A.F.G. Hahn. 1996. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 47 (Nov.): 1317-1320.

Moulin, D.E., N. Hagen, T.E. Feasby, R. Amireh, and A.F.G. Hahn. 1997. Pain in Guillain-Barré syndrome. Neurology 48 (Feb.): 328-331.

Zifko, U.A., and A.F.G. Hahn. 1997. Migrant sensory neuritis: report of 5 cases and review of the literature. Journal of the Peripheral Nervous System 2 (3): 244-249.

Zifko, U.A., A.F.G. Hahn, H. Remtulla, C.F.P. George, W. Wihlidal, and C.F. Bolton. 1996. Central and peripheral respiratory electrophysiologic studies in myotonic dystrophy. Brain 119: 1911-1922.

 

KARLIK, S. J.

Cadera, W., J.N. Bloom, S.J. Karlik, and E. Viirre. 1997. A magnetic resonance imaging study of double elevator palsy. Canadian Journal of Ophthalmology 32 (4): 250-253.

Keszthelyi, E., S.J. Karlik, S. Hyduk, G.P.A. Rice, G. Gordon, T. Yednock, and H.C. Horner. 1996. Evidence for a prolonged role of alph 4 integrin throughout active experimental allergic encephlomylitis. Neurology 47 (4): 1054-1059.

Mitchell, J.R., C. Jones, S.J. Karlik, K. Kennedy, D.H. Lee, B.K. Rutt, and A. Fenster. 1997. MR Multispectral Analysis of Multiple Sclerosis Lesions. Journal of Magnetic Resonance Imaging 7 (3): 499-511.

 

KERTESZ, A.

Kertesz, A. 1996. Cerebral Asymmetries and Corpus Callosum Morphology (Chapter 6). Neuroimaging I: Basic Science. E.D. Bigler. New York, NY: Plenum Press. 119-131.

Kertesz, A. 1996. Frontotemporal and corticobasal degeneration and their relationship to Pick's disease and ALS. Ideggyogyaszati Szemie 49: 5-7.

Kertesz, A. 1997. A Mensch (Chapter 3). Behavioural Neurology and The Legacy of Norman Geschwind. S.C. Schachter, and O. Devinsky. New York, NY: Lippincott- Raven Press. 15-19.

Kertesz, A. 1997. Overview: Language Disorders. Clinical Neuroscience 4: 49-50.

Kertesz, A. 1997. Recovery in Language Networks. Aphasietherapie im Wandel. W. Widdig, I.M. Ohlendorf, and J.P. Malin. Freiburg, Germany: Hochschul Verlag. 15-30.

Kertesz, A. 1997. Recovery of Aphasia (Chapter 11). Behavioural Neurology and Neuropsychology. T.E. Feinberg, and M.J. Farah. Toronto, ON: McGraw Hill, Health Professions Division. 167-182.

Kertesz, A., W. Davidson, and H. Fox. 1997. Frontal Behavioral Inventory: Diagnostic Criteria for Frontal Lobe Dementia. Canadian Journal of Neuorological Sciences 24 (1): 29-36.

Kertesz, A., and P. Kalvach. 1996. Arnold Pick and German Neuropsychiatry in Prague. Archives of Neurology 53 (Sept.): 935-938.

Kertesz, A., and D.G. Munoz. 1996. Clinical and Pathological Characteristics of Primary Progressive Aphasia and Frontal Dementia. Journal of Neural Transmission 47 (Supplement): 133-141.

Kertesz, A., and D.G. Munoz. 1997. Primary Progressive Aphasia. Clinical Neuroscience 4: 95-102.

 

LEE, D. H.

Lee, D.H., F. Gao, R.N. Rankin, D.M. Pelz, and A.J. Fox. 1996. Duplex and Color Doppler Flow Sonography of Occlusion and Near Occlusion of the Carotid Artery. American Journal of Neuroradiology 17 (Aug.): 1267-1274.

Lee, D.H., and V. Hachinski. 1996. Brain Imaging In Stroke. Americal Journal of Neuroradiology 17 (Aug.): 1265-1266.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Mitchell, J.R., C. Jones, S.J. Karlik, K. Kennedy, D.H. Lee, B.K. Rutt, and A. Fenster. 1997. MR Multispectral Analysis of Multiple Sclerosis Lesions. Journal of Magnetic Resonance Imaging 7 (3): 499-511.

Sahjpaul, R.L., D.H. Lee, and D.G. Munoz. 1997. Fatal reaction following inadvertant intrathecal administration of ionic contrast agent. Acta Neuropathologica 93: 101-103.

 

LEUNG, L. W. S.

Leung, L.W.S., D. Brzozowski, and B. Shen. 1996. Partial hippocampal kindling affects retention but not acquisition and place but not cue tasks on the radial arm maze. Behavioral Neuroscience 110 (5): 1017-1024.

Ma, J., S.M. Brudzynski, and L.W.S. Leung. 1996. Involvement of the nucleus accumbens - ventral pallidal pathway in postictal behavior induced by a hippocampal afterdischarge in rats. Brain Research 739: 26-35.

 

LEVIN, S. D.

McLachlan, R.S., S.D. Levin, and W.T. Blume. 1997. Treatment of Rasmussen's syndrome with Ganciclovir. Neurology 47: 925-928.

 

LOWNIE, S. P.

Pelz, D.M., S.P. Lownie, D. Rosso, and A.J. Fox. 1997. Cerebral dural arteriovenous fistulae with pial venous drainage: combined endovascular-neurosurgical therapy. Canadian Journal of Neurological Sciences 24: 210-218.

 

MACDONALD, D. R.

Fisher, B.J., J. Siddiqui, D.R. Macdonald, A.E.L. Cairney, D.A. Ramsay, D.G. Munoz, and R.F. Del Maestro. 1996. Malignant rhabdoid tumor of brain: An aggressive clinical entity. Canadian Journal of Neurological Sciences 23 (4): 257-263.

Irish, W.D., D.R. Macdonald, and J.G. Cairncross. 1997. Measuring bias in uncontrolled brain tumor trials - to randomize or not to randomize? Canadian Journal of Neurological Sciences 24: 307-312.

Leighton, C., B.J. Fisher, G. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Li, Y.S., D.A. Ramsay, D.R. Macdonald, and R.F. Del Maestro. 1997. Therapy-related changes and cytogenetic heterogeneity in human gliomas. Journal of Neuro-Oncology 32: 7-17.

Macdonald, D.R. 1996. Neurotoxicity of Chemotherapeutic Agents (Chapter 38). The Chemotherapy Source Book. 2nd ed. M.C. Perry. Baltimore, MD: Williams and Wilkins. 745-765.

Peterson, K., N. Paleologos, P. Forsyth, D.R. Macdonald, J.G. Cairncross, and The Oligodendroglioma Study Group. 1996. Salvage chemotherapy for oligodendroglioma. Journal of Neurosurgery 85 (Oct.): 597-601.

 

MACKENZIE, I. R. A.

Gouras, G.K., N.R. Relkin, D. Sweeney, D.G. Munoz, I.R.A. MacKenzie, and S. Gandy. 1997. Increased Apolipoprotein E E4 in Epilepsy with Senile Plaques. Annals of Neurology 41 (3): 402-404.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

 

MANCHANDA, R.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

 

MCLACHLAN, R. S.

Bailiff, C., J. Bruni, Camfield, S. Cowan, R.S. McLachlan, and G.B. Young. 1997. Anti-epileptic Drug Therapy. Compendium of Pharmaceuticals and Specialties (CPS). 1997 ed. Toronto, ON: Canadian Pharmaceutical Association.

Blume, W.T., J.P. Girvin, R.S. McLachlan, and B. Gilmore. 1997. Effective temporal lobectomy in childhood without invasive EEG. Epilepsia 38 (2): 164-167.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, M. Eliasziw, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Maher, J., and R.S. McLachlan. 1997. Febrile Convulsions in Selected Large Families: A single major locus mode of inheritance. Developmental Medicine and Child Neurology 39: 79-84.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

McLachlan, R.S. 1997. A Quick Guide to EEG Rhythms. Meducom International.

McLachlan, R.S. 1996. Sudden Seizure Exacerbation: An Alternative Explanation. Challenges in Epilepsy 1 (3): 3-4.

McLachlan, R.S., S.D. Levin, and W.T. Blume. 1997. Treatment of Rasmussen's syndrome with Ganciclovir. Neurology 47: 925-928.

McLachlan, R.S., K.J. Rose, P.A. Derry, C. Bonnar, W.T. Blume, and J.P. Girvin. 1997. Health-related quality of life and seizure control in temporal lobe epilepsy. Annals of Neurology 41: 482-489.

Wiebe-Velazquez, S., K.J. Rose, P.A. Derry, and R.S. McLachlan. 1997. Outcome Assessment in Epilepsy: Comparative Responsiveness of quality of Life and Psychosocial Instruments. Epilepsia 38: 430-438.

 

MOULIN, D. E.

Moulin, D.E. 1997. Approach to the patient with chronic pain syndromes. Textbook of Internal Medicine. 3rd ed. W.N. Kelley, H.L. Dupont, et al. Philadelphia, PA: Lippincott-Raven. 212-215.

Moulin, D.E. 1997. Editiorial- Relative potency estimates of analgesics- are they perceived or real? Pain Research and Management 1: 195-196.

Moulin, D.E. 1996. Editorial- Pain assessment and management in Multiple Sclerosis. The International MS Journal 3: 59-63.

Moulin, D.E., N. Hagen, T.E. Feasby, R. Amireh, and A.F.G. Hahn. 1997. Pain in Guillain-Barré syndrome. Neurology 48 (Feb.): 328-331.

 

MUNOZ, D. G.

Bowler, J.V., M. Eliasziw, R. Steenhuis, D.G. Munoz, R. Fry, H. Merskey, and V. Hachinski. 1997. Comparative evolution of Alzheimer disease, vascular dementia and mixed dementia. Archives of Neurology 54 (June): 697-703.

Fisher, B.J., J. Siddiqui, D.R. Macdonald, A.E.L. Cairney, D.A. Ramsay, D.G. Munoz, and R.F. Del Maestro. 1996. Malignant rhabdoid tumor of brain: An aggressive clinical entity. Canadian Journal of Neurological Sciences 23 (4): 257-263.

Gouras, G.K., N.R. Relkin, D. Sweeney, D.G. Munoz, I.R.A. MacKenzie, and S. Gandy. 1997. Increased Apolipoprotein E E4 in Epilepsy with Senile Plaques. Annals of Neurology 41 (3): 402-404.

Hudson, A.J., and D.G. Munoz. 1997. A Familial Syndrome of Congenital Cataract, Mental Impairment, and Dentate Gyrus Atrophy. Annals of Neurology 41 (4): 512-520.

Hutnik, C.M.L., D.A. Nicolle, and D.G. Munoz. 1997. Orbital Aspergillosis - a Fatal Masquerader. Journal of Neuro-Ophthalmology 17 (4): 257-261.

Kertesz, A., and D.G. Munoz. 1996. Clinical and Pathological Characteristics of Primary Progressive Aphasia and Frontal Dementia. Journal of Neural Transmission 47 (Supplement): 133-141.

Kertesz, A., and D.G. Munoz. 1997. Primary Progressive Aphasia. Clinical Neuroscience 4: 95-102.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Martinez-Lage, P., and D.G. Munoz. 1997. Prevalence and Disease Associations of Argyrophilic Grains of Braak. Journal of Neuropathology and Experimental Neurology 56 (2): 157-164.

Sahjpaul, R.L., D.H. Lee, and D.G. Munoz. 1997. Fatal reaction following inadvertant intrathecal administration of ionic contrast agent. Acta Neuropathologica 93: 101-103.

Stemmer-Rachamimov, A.O., M.A. Horgan, L. Taratuto, D.G. Munoz, T.W. Smith, M.P. Frosch, and D.N. Louis. 1997. Meningioangiomatosis is Associated with Neurofibromatosis 2 but not with Somatic Alterations of the NF2 Gene. Journal of Neuropathology and Experimental Neurology 56 (5): 485-489.

 

NAUS, C. C.

Bani-Yaghoub, M., J.F. Bechberger, and C.C. Naus. 1997. Reduction of Connexin43 Expression and Dye-Coupling During Neuronal Differentiation of Human NTera2/Clone D1 Cells. Journal of Neuroscience Research 49: 19-31.

Bechberger, J.F., N.S.K. Khoo, and C.C. Naus. 1996. Analysis of Connexin43 Expression Under the Control of a Metallothionein Promoter. Cell Growth and Differentiation 7 (Oct.): 1403-1413.

Dilber, M.S., M.R. Abedi, B. Christensson, B. Bjorkstrand, G.M. Kidder, C.C. Naus, G. Gahrton, and C.I.E. Smith. 1997. Gap Junctions Promote the Bystander Effect of Herpes Simplex Virus Thymidine Kinase in Vivo. Cancer Research 57 (April): 1523-1528.

Luo, C., S.H. MacPhail, G.J. Dougherty, C.C. Naus, and P.L. Olive. 1997. Radiation Response of Connexin43-Transfected Cells in Relation to the "Contact Effect". Experimental Cell Research 234: 225-232.

Naus, C.C., J.F. Bechberger, and S.L. Bond. 1996. Effect of Gap Junctional Communication on Glioma Cell Function (Chapter 11). Gap Junctions in the Nervous System. D.C. Spray, and R. Dermietzel. Austin, Texas: R.G. Landes Co. 193-202.

Naus, C.C., J.F. Bechberger, Y. Zhang, L. Venance, H. Yamasaki, S.C. Juneja, G.M. Kidder, and C. Giaume. 1997. Altered Gap Junctional Communication, Intercellular Signaling, and Growth in Cultured Astrocytes Deficient in Connexic43. Journal of Neuroscience Research 49: 528-540.

Perez Velazquez, J.L., M. Frantseva, C.C. Naus, J.F. Bechberger, S.C. Juneja, A. Velumian, P.L. Carlen, G.M. Kidder, and L.R. Mills. 1996. Development of Astrocytes and Neurons in Cultured Brain Slices from Mice Lacking Connexin43. Developmental Brain Research 97: 293-296.

Proulx, A.A., Z.X. Lin, and C.C. Naus. 1997. Transfection of Rhabdomyosarcoma Cells with Connexin43 Induces Myogenic Differentiation. Cell Growth and Differentiation 8 (May): 533-540.

Proulx, A., P.A. Merrifield, and C.C. Naus. 1997. Blocking Gap Junctional Intercellular Communication in Myoblasts Inhibits Myogenin and MRF4 Expression. Developmental Genetics 20: 133-144.

Rajakumar, N., W. Rushlow, B. Rajakumar, C.C. Naus, A.J. Stoessl, and B.A. Flumerfelt. 1997. Effects of Graft-derived Dopaminergic Innervation on the Target Neurons of Patch and Matrix Compartments of the Striatum. Neuroscience 76 (4): 1173-1185.

 

NICOLLE, D. A.

Desousa, J.F., D.A. Nicolle, and T. Vilis. 1997. Task-dependent Changes in the Shape and Thickness of Listing's Plane. Vision Research 37 (16): 2271-2282.

Hutnik, C.M.L., D.A. Nicolle, and C.L.B. Canny. 1996. Papillitis: A Rare Initial Presentation of Crohn's Disease. Canadian Journal of Ophthalmology 31 (7): 373-376.

Hutnik, C.M.L., D.A. Nicolle, and D.G. Munoz. 1997. Orbital Aspergillosis - a Fatal Masquerader. Journal of Neuro-Ophthalmology 17 (4): 257-261.

Rafuse, P.E., D.A. Nicolle, C.M.L. Hutnik, and C.E. Pringle. 1997. Left Atrial Myxoma Causing Ophthalmic Artery Occlusion. Eye 11 (1): 25-29.

Schmidt, M., D.A. Nicolle, and A.J. Fox. 1997. Bilateral Anterior Ischemic Optic Neuropathy as a Presentation of Takayasu's Disease. Journal of Neuro-Ophthalmology 17 (3): 156-161.

 

NICOLLE, M. W.

Bond, A., L. Corlett, N. Nagvekar, L. Jacobson, N. Pantic, D. Beeson, M.W. Nicolle, A. Vincent, J. Newsome-Davis, E. Spack, and N. Willcox . 1997. Hetereogeneity and immunotherapy of specific T-cells in myasthenia gravis. Biochemistry Society Transactions 25: 655-670.

Nicolle, M.W., D.J. Stewart, H. Remtulla, R. Chen, and C.F. Bolton. 1996. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle and Nerve 19 (Oct.): 1328-1333.

 

PARNES, L. S.

de Kok, Y.J.M., E.R. Vossenaar, C.W.R.J. Cremers, N. Dahl, J. Laporte, L.J. Hu, D. Lacombe, N. Fischel-Ghodsian, R.A. Friedman, L.S. Parnes, P. Thorpe, M. Bitner-Glindzicz, H.J. Pander, H. Heilbronner, J. Graveline, J.T. den Dunnen, H.G. Brunner, H.H. Ropers, and F.P.M. Cremers. 1996. Identification of a hot spot for Microdeletions in Patients with X-linked Deafness Type 3 (DFN3) 900 kb Proximal to the DFN3 Gene POU3F4. Human Molecular Genetics 5 (9): 1229-1235.

Parnes, L.S., and J. Robichaud. 1997. Further Observations During the Particle Repositioning Maneuver for Benign Paroxysmal Positional Vertigo. Otolaryngology - Head and Neck Surgery 116 (2): 238-243.

Parnes, L.S., and R. Sindwani. 1997. Impact of Vestibular Disorders on Fitness to Drive: A Census of the American Neurotology Society. The American Journal of Otology 18 (1): 79-85.

Sindwani, R., and L.S. Parnes. 1997. Reporting of Vestibular Patients Who are Unfit to Drive: Survey of Canadian Otolaryngologists. The Journal of Otolaryngology 26 (2): 104-111.

Welling, D.B., L.S. Parnes, B. O'Brien, L.O. Bakaletz, D.E. Brackmann, and R. Hinojosa. 1997. Particulate Matter in the Posterior Semicircular Canal. The Laryngoscope 107 (Jan.): 90-94.

 

PARRENT, A. G.

Herrick, I.A., R.A. Craen, A.W. Gelb, R.S. McLachlan, J.P. Girvin, A.G. Parrent, M. Eliasziw, and J. Kirkby. 1997. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesthesia and Analgesia 84: 1280-1284.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

 

PELZ, D. M.

Lee, D.H., F. Gao, R.N. Rankin, D.M. Pelz, and A.J. Fox. 1996. Duplex and Color Doppler Flow Sonography of Occlusion and Near Occlusion of the Carotid Artery. American Journal of Neuroradiology 17 (Aug.): 1267-1274.

Pelz, D.M., S.P. Lownie, D. Rosso, and A.J. Fox. 1997. Cerebral dural arteriovenous fistulae with pial venous drainage: combined endovascular-neurosurgical therapy. Canadian Journal of Neurological Sciences 24: 210-218.

 

RAMSAY, D. A.

Fisher, B.J., J. Siddiqui, D.R. Macdonald, A.E.L. Cairney, D.A. Ramsay, D.G. Munoz, and R.F. Del Maestro. 1996. Malignant rhabdoid tumor of brain: An aggressive clinical entity. Canadian Journal of Neurological Sciences 23 (4): 257-263.

Li, Y.S., D.A. Ramsay, D.R. Macdonald, and R.F. Del Maestro. 1997. Therapy-related changes and cytogenetic heterogeneity in human gliomas. Journal of Neuro-Oncology 32: 7-17.

Rupar, C.A., J.M.R. Gillett, B.A. Gordon, D.A. Ramsay, J.L. Johnson, R.M. Garrett, K.V. Rajagopolan, J.H. Jung, G.S. Bacheyie, and A.R. Sellers. 1997. Isolated Sulfite Oxidase Deficiency. Neuropediatrics 27: 299-304.

 

RICE, G. P. A.

Keszthelyi, E., S.J. Karlik, S. Hyduk, G.P.A. Rice, G. Gordon, T. Yednock, and H.C. Horner. 1996. Evidence for a prolonged role of alph 4 integrin throughout active experimental allergic encephlomylitis. Neurology 47 (4): 1054-1059.

Paty, D.W., D. Goodkin, A. Thompson, and G.P.A. Rice. 1996. Guidelines for physicians with patients on IFNB-1b: The use of an assay for neutralizing antibodies. Neurology 47: 865-866.

Rice, G.P.A., and Cladribine Study Group. 1997. Cladribine and chronic progressive multiple sclerosis: The results of a multicenter trial. Neurology 48 (6): 1730.

Rice, G.P.A., J. Lesaux, M. Vandervoort, L. Macewan, and G.C. Ebers. 1997. Ondansetron, a 5-HT3 antagonist improves cerebellar tremor. Journal of Neurology, Neurosurgery and Psychiatry 62: 282-284.

 

ROGERS, J. M.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparison of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

 

SAHJPAUL, R. L.

Clifford, S.S., R.L. Sahjpaul, and J.G. Cairncross. 1997. Chemotherapy of primary brain tumors. Neurosurgery. 2nd edition ed. McGraw-Hill. 1957-1967.

Sahjpaul, R.L., D.H. Lee, and D.G. Munoz. 1997. Fatal reaction following inadvertant intrathecal administration of ionic contrast agent. Acta Neuropathologica 93: 101-103.

Schold, S.C.J.R., J.G. Cairncross, and R. Sahjpaul. 1996. Chemotherapy of Primary Central Nervous System Neoplasms. Neurosurgery. R.H. Wilkins, and S.S. Rengachary. New York, NY: McGraw-Hill. 1957-1966.

 

SPENCE, J. D.

Bailey, D.G., J.R. Bend, J.M.O. Arnold, L.T. Tran, and J.D. Spence. 1996. Erythromycin- Felodipine interaction: magnitude, mechanism and comparison with grapefruit juice. Clinical Pharmacology and Therapeutics 60: 25-33.

Barnett, P.A., J.D. Spence, S.B. Manuck, and J.R. Jennings . 1997. Psychological stress and the progression of carotid artery disease. Journal of Hypertension 15: 49-55.

Kurowska, E., J. Jordan, J.D. Spence, S.J. Wetmore, L.A. Piche, M. Radzikowski, P. Dandona, and K.K. Carroll. 1997. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clinical and Investigative Medicine 20: 162-170.

Rau, S.E., J.R. Bend, J.M.O. Arnold, L.T. Tran, J.D. Spence, and D.G. Bailey. 1997. Grapefruit juice- terfenadine single-dose interatction: Magnitude, mechanism and relevance. Pharmacokinetics and Drug Dispostion 61: 401-409.

Sherebrin, S., A. Fenster, R.N. Rankin, and J.D. Spence. 1997. Freehand three-dimensional ultrasound: implementation and applications. SPIE Proceedings (Proceedings of the Society of Photo-Optical Instrumentation Engineers) 2708: 296-303.

Spence, J.D. 1996. Cerebral Vascular Consequences of Hypertension: Where Do they Lead? Journal of Hypertension 14: S139-S145.

Spence, J.D. 1997. Drug Interactions with Grapefruit Juice: Whose Responsibility is it to Warn the Public? Clinical Pharmacology and Therapeutics 61: 395-400.

 

STRONG, M. J.

Brooke, M.H., and M.J. Strong. 1996. Advances in ALS Workship Summary: Research and Future Goals. Neurology 47 (Supplement 2): S108-S112.

Crow, J.P., Y.Z. Ye, M.J. Strong, M. Kirk, S. Barnes, and J.S. Beckman. 1996. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. Journal of Toxicology and Environmental Health 48: 599-613.

Cunningham, K., C.R. Sopper, and M.J. Strong. 1997. Enhance ex vivo cosedimentation of high molecular weight neurofilament protein (NFH) with microtubules following in vivo aluminum chloride exposure. Inhibition of dephosphorylation dependant dissociation. Neurotoxicology 18 (2): 355-362.

Sampson, J.B., J.P. Crow, M.J. Strong, and J.S. Beckman. 1997. Copper/Zinc Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis, Tyrosine Nitration Catalysis as a Possible Mutation Gain in Function (Chapter 39). Mineral and Metal Neurotoxicology. M. Yasui, et al. Boca Raton, FL: CRC Press. 393-403.

Strong, M.J. 1997. Modeling of Acute and Chronic Aluminum Neurotoxicity (Chapter 10). Mineral and Metal Neurotoxicology. M. Yasui, et al. Boca Raton, FL: CRC Press. 99-106.

Strong, M.J., and R.M. Garruto. 1997. Motor Neuron Disease (Chapter 11). Mineral and Metal Neurotoxicology. M. Yasui, et al. Boca Raton, FL: CRC Press. 107-112.

Strong, M.J., R.M. Garruto, J.G. Joshi, W.R. Mundy, and T.J. Shafer. 1997. Can the mechanisms of aluminum neurotoxicity be integrated into a unified scheme? Research Issues in Aluminum Toxicity. Taylor and Francis.

Wakayama, I., V.R. Nerurkar, M.J. Strong, and R.M. Garruto . 1996. Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of ALS. Acta Neuropathologica 92: 545-554.

Yasui, M., M.J. Strong, A. Verity, and K. Ota. 1997. Mineral and Metal Neurotoxicology. Boca Raton, FL: CRC Press. 464 pp. Includes bibliographical references and index.

 

WIEBE-VELAZQUEZ, S.

Manchanda, R., B. Schaefer, R.S. McLachlan, W.T. Blume, S. Wiebe-Velazquez, J.P. Girvin, A.G. Parrent, and P.A. Derry. 1996. Psychiatric disorders in candidates for surgery for epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 61 (1): 82-89.

Wiebe-Velazquez, S. 1997. Evidence-based medicine: What to expect after a first generalized seizure. Medicine North America 19 (7): 10-16.

Wiebe-Velazquez, S., K.J. Rose, P.A. Derry, and R.S. McLachlan. 1997. Outcome Assessment in Epilepsy: Comparative Responsiveness of quality of Life and Psychosocial Instruments. Epilepsia 38: 430-438.

 

WILLIAMSON, P. C.

Bartha, R., P.C. Williamson, D.J. Drost, A.K. Malla, T.J. Carr, L. Cortese, G. Canaran MacFabe, R.J. Rylett, and R.W.J. Neufeld. 1997. Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls Using Proton Magnetic Resonance Spectroscopy. Archives of General Psychiatry 54: 959-965.

Hinsberger, A.D., P.C. Williamson, T.J. Carr, J.A. Stanley, D.J. Drost, M. Densmore, G. Canaran MacFabe, and D.G. Montemurro. 1997. Magnetic Resonance Imaging Volumetric Measures and Phosphorus 31 Magnetic Resonance Spectroscopy Measurements in Schizophrenia. Journal of Psychiatry and Neuroscience 22 (2): 111-117.

Norman, R.M.G., A.K. Malla, S. Morrison-Stewart, E. Helmes, P.C. Williamson, J. Thomas, and L. Cortese. 1997. Neuropsychological Correlates of Syndromes in Schizophrenia. British Journal of Psychiatry 170: 134-139.

Potwarka, J., D.J. Drost, and P.C. Williamson. 1997. A 2D 31P Chemical Shift Imaging Study with 1H Decoupling of Medicated Schizophrenics and Healthy Controls. Society of Magnetic Resonance Proceedings, Volume 2. Vancouver, BC: 1224.

Stanley, J.A., P.C. Williamson, D.J. Drost, R.J. Rylett, T.J. Carr, A.K. Malla, and R.T. Thompson. 1996. An In Vivo Proton Magnetic Resonance Spectroscopy Study of Schizophrenic Patients. Schizophrenia Bulletin 22 (4): 597-609.

 

YOUNG, G. B.

Bailiff, C., J. Bruni, Camfield, S. Cowan, R.S. McLachlan, and G.B. Young. 1997. Anti-epileptic Drug Therapy. Compendium of Pharmaceuticals and Specialties (CPS). 1997 ed. Toronto, ON: Canadian Pharmaceutical Association.

Bolton, C.F., and G.B. Young. (Editors). 1996. Baillière's Clinical Neurology: International Practice and Research, Critical Care. 5 (3). 245 pp. C.F. Bolton and G.B. Young (Guest Editors).

Bolton, C.F., and G.B. Young. 1996. Neurologic Consultation and Neurological Syndromes in Intensive Care Unit (Chapter 1). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 447-476.

Chen, R., and G.B. Young. 1997. Metabolic encephalopathies (Chapter 7). Bailliere's Clinical Neurology: International Practice and Research, Critical Care 5 (3): 577-598.

McKeown, M., and G.B. Young. 1997. Comparison between the Alpha pattern in normal subjects and in Alpha pattern coma. Journal of Clinical Neurophysiology 14 (4): 1-5.

Young, G.B. 1997. The encephalopathy associated with septic illness: Clinical Neurolgical features. Shock Sepsis and Organ Failures. Heidelberg: Spinger-Verlog. 94-106.

Young, G.B. 1997. Ethics (Chapter 11). Bailliere's Clincial Neurology: International Practice and Reserch, Critical Care 5 (3): 673-684.